TD Cowen analyst Gary Taylor raised the firm’s price target on HCA Healthcare (HCA) to $490 from $380 and keeps a Buy rating on the shares. The firm said they reported a strong quarter with adjusted EBITDA +11% ahead of consensus and raised FY25 EBITDA Guide by more than $450m at the midpoint.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- HCA Healthcare price target raised to $494 from $445 at Barclays
- HCA Healthcare price target raised to $525 from $495 at UBS
- HCA Healthcare price target raised to $520 from $470 at Goldman Sachs
- HCA Healthcare price target raised to $425 from $400 at Morgan Stanley
- HCA Healthcare price target raised to $525 from $444 at Cantor Fitzgerald